U.S. patent 5945452: Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity. Granted to Cooke et. al. on 1999-08-31 (filed None). Currently involved in at least 1 patent litigation: All American Pharmaceutical and Natural Foods Corp. v. Thermolife International (Montana). See http://news.priorsmart.com for more info.
Original Title
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity (US patent 5945452)
U.S. patent 5945452: Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity. Granted to Cooke et. al. on 1999-08-31 (filed None). Currently involved in at least 1 patent litigation: All American Pharmaceutical and Natural Foods Corp. v. Thermolife International (Montana). See http://news.priorsmart.com for more info.
U.S. patent 5945452: Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity. Granted to Cooke et. al. on 1999-08-31 (filed None). Currently involved in at least 1 patent litigation: All American Pharmaceutical and Natural Foods Corp. v. Thermolife International (Montana). See http://news.priorsmart.com for more info.